Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
出版年份 2017 全文链接
标题
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
作者
关键词
-
出版物
npj Genomic Medicine
Volume 2, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-03
DOI
10.1038/s41525-017-0013-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CT Textural Analysis of Large Primary Renal Cell Carcinomas: Pretreatment Tumor Heterogeneity Correlates With Histologic Findings and Clinical Outcomes
- (2016) Meghan G. Lubner et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Varying Mutational Alterations in Multiple Primary Melanomas
- (2016) Friederike Egberts et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
- (2016) Jill M. Spoerke et al. Nature Communications
- Genomic heterogeneity of multiple synchronous lung cancer
- (2016) Yu Liu et al. Nature Communications
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
- (2016) Zachary A. Cooper et al. OncoImmunology
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Unfolding the Mutational Landscape of Human Melanoma
- (2015) Diwakar Davar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ibex: An open infrastructure software platform to facilitate collaborative work in radiomics
- (2015) Lifei Zhang et al. MEDICAL PHYSICS
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
- (2015) Richard Kim et al. PLoS One
- Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
- (2015) J. Zachary Sanborn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels
- (2015) Byungho Lim et al. Oncotarget
- CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?
- (2015) Sheng-Xiang Rao et al. United European Gastroenterology Journal
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers
- (2014) Sun Young Lee et al. PLoS One
- Clonal Architectures and Driver Mutations in Metastatic Melanomas
- (2014) Li Ding et al. PLoS One
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas
- (2013) Marco Gerlinger et al. JOURNAL OF PATHOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Assessment of tumor heterogeneity by CT texture analysis: Can the largest cross-sectional area be used as an alternative to whole tumor analysis?
- (2012) Francesca Ng et al. EUROPEAN JOURNAL OF RADIOLOGY
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiomics: the process and the challenges
- (2012) Virendra Kumar et al. MAGNETIC RESONANCE IMAGING
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers
- (2008) C. Lundegaard et al. BIOINFORMATICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- The immunologic constant of rejection
- (2008) Ena Wang et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation